Mind Body Syndrome (MBS) Therapy for the Treatment of Chronic Pain

Not Applicable

Completed

• Conditions: Chronic Pain
• Interventions: Behavioral: One-on-one interview and educational sessions. Reading material for educational series provided.

• Registration Number: NCT02117921
• Lead Sponsor: Beth Israel Deaconess Medical Center

Brief Summary

To determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients suffering from chronic pain syndromes without organic etiology.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-02
• Study First Submitted: 2014-04-16
• Study First Submitted QC: 2014-04-16
• Study First Posted: 2014-04-21
• Primary Completion: 2016-12
• Study Completion: 2016-12
• Status Verified: 2024-09
• Last Update Submitted: 2024-09-28
• Last Update Posted: 2024-10-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Adult patient 18 > years old
• Chronic pain without clear organic etiology after full evaluation by primary care physician or subspecialist
• Pain persistent for a minimum of 3 days a week for the past three months prior to enrollment

Exclusion Criteria

• Patients < 18 years of age
• Diagnosed organic disease as cause of pain, such as but not limited to malignancy, neurologic disorder (i.e., amyotrophic lateral sclerosis)
• Patients with a diagnosis of significant psychiatric co-morbidities such as schizophrenia and bi-polar disorder. Mild to moderate depression and anxiety will not be considered as exclusions
• Pregnancy
• Severe depression or recent suicide attempt

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
MBS therapy education	One-on-one interview and educational sessions. Reading material for educational series provided.	-

Primary Outcome Measures

Name	Time	Method
SF-12 Health Survey Scoring Demonstration	4 weeks
Brief Pain Inventory Questionnaire	4 weeks	To determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients suffering from chronic pain syndromes without organic etiology.

Secondary Outcome Measures

Name	Time	Method
SF-12 Health Survey Scoring Demonstration and Brief Pain Inventory Score	2 weeks, 4 weeks, 6 months

Trial Locations

Locations (1)

Beth Israel Deaconess Medical Center; 🇺🇸 Boston, Massachusetts, United States